ORIGINAL RESEARCH
Accepted on 02 Apr 2025
Immunotherapy for Neuromyelitis Optica Spectrum Disorder: A Comparative Analysis of Efficacy and Safety of Azathioprine, Mycophenolate Mofetil, Tacrolimus, and Rituximab
doi 10.3389/fneur.2025.1559118
- Frontiers in Neurology
- Multiple Sclerosis and Neuroimmunology
- Research Topics
- Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases.
Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases.
3,283
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 04 Mar 2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
doi 10.3389/fimmu.2025.1527102
- 365 views
CASE REPORT
Published on 17 Jan 2025
Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report
doi 10.3389/fimmu.2024.1517943
- 623 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
doi 10.3389/fneur.2024.1500763
- 1,095 views
ORIGINAL RESEARCH
Published on 12 Nov 2024
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
doi 10.3389/fimmu.2024.1480676
- 1,531 views
ORIGINAL RESEARCH
Published on 06 Nov 2024
A comparison of natalizumab’s effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients
doi 10.3389/fneur.2024.1475161
- 560 views
ORIGINAL RESEARCH
Published on 24 Oct 2024
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis
doi 10.3389/fneur.2024.1473284
- 1,450 views
ORIGINAL RESEARCH
Published on 15 Jul 2024
Hyper-reflective foci changes in RRMS under natalizumab therapy
doi 10.3389/fimmu.2024.1421755
- 805 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jun 2024
Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain
doi 10.3389/fneur.2024.1408759
- 785 views
CASE REPORT
Published on 05 Jun 2024
A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab
doi 10.3389/fneur.2024.1371515
- 1,023 views
Published in
Frontiers in Neurology
Multiple Sclerosis and Neuroimmunology
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: